Suchergebnisse - "KE CHANGWEN"

PubPharm (270)

41

Significantly reduced abilities to cross-neutralize SARS-CoV-2 variants by sera from convalescent COVID-19 patients infected by Delta or early strains

enthalten in: Cellular & molecular immunology | 2021

von Pan, T. | Hu, Z. | Hu, F. | +7

CommentIn: Signal Transduct Target Ther. 2021 Dec 17;6(1):430. - PMID 34921135

42

The Dynamics of Neutralizing Antibody Level in One Year After SARS-CoV-2 Infection

enthalten in: ResearchSquare.com | 2021

von Liang, D. | Zhang, G. | Huang, M. | +13

43

Single-shot rAAV5-based Vaccine Provides Long-term Protective Immunity against SARS-CoV-2 and Its Variants

enthalten in: bioRxiv.org | 2021

von Liao, G. | Fan, X. | Lau, H. | +30

44

Author Correction : Setting a baseline for global urban virome surveillance in sewage

enthalten in: Scientific reports | 2021

von Nieuwenhuijse, D. | Oude Munnink, B. | Phan, M. | +106

ErratumFor: Sci Rep. 2020 Aug 13;10(1):13748. - PMID 32792677

45

Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery

enthalten in: Nature communications | 2021

von Feng, C. | Shi, J. | Fan, Q. | +19

46

Capturing noroviruses circulating in the population : sewage surveillance in Guangdong, China (2013-2018)

enthalten in: Water research | 2021

von Lu, J. | Peng, J. | Fang, L. | +17

47

A High-Coverage SARS-CoV-2 Genome Sequence Acquired by Target Capture Sequencing

enthalten in: bioRxiv.org | 2021

von Wen, S. | Sun, C. | Zheng, H. | +13

48

Comparison of SARS-CoV-2 infections among 3 species of non-human primates

enthalten in: bioRxiv.org | 2021

von Lu, S. | Zhao, Y. | Yu, W. | +31

49

Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates

enthalten in: ACS nano | 2021

von Kang, Y. | Sun, C. | Zhuang, Z. | +18

50

Differential Antibody Response to Inactivated COVID-19 Vaccines in Healthy Subjects

enthalten in: Frontiers in cellular and infection microbiology | 2021

von Zhang, J. | Xing, S. | Liang, D. | +18